The Centers for Medicare & Medicaid Services (CMS) issued an unprecedented decision that blocks Medicare coverage of FDA-approved treatments that target amyloid for Alzheimer's disease. Join us in asking Congress to call on CMS to change this decision. TAKE ACTION for those living with Alzheimer's by asking Congress to Ensure Access to FDA-Approved Alzheimer's Treatments. We must improve the care, support and research for the 6.7 million Americans living with #Alzheimers 

#ENDALZ advocates from across the country this week in Washington, D.C. for the 2023 AIM Advocacy Forum. Together, they will work to advance policies to improve the lives of all individuals affected by Alzheimer’s and all other dementia. #alzforum #abwp